Marine Biology-Online-Journals
Marine biology may be a younger science than terrestrial biology as early scientists were limited in their study of aquatic organisms by lack of technology to watch and sample them. The Greek philosopher Aristotle was one among the firsts to style a classification scheme for living organisms, which he called “the ladder of life” and during which he described 500 species, several of which were marine. He also studied fish gills and cuttlefish. The Roman naturalist Pliny the Elder published a 37-volume work called explanation , which contained several marine species. Little work on explanation was conducted during the center ages, and it wasn’t until the late 18th century and early 19th century that interest within the marine
environment was renewed, fueled by explorations now made possible by better ships and improved navigation techniques. In 1831, Darwin set sail for a 5 year circumnavigation on the HMS Beagle, and his observations of organisms during this voyage later led to his elaboration of the idea of
evolution by survival.
Darwin also developed a hypothesis on the formation of atolls, which clothed to be correct. within the early 19th century, English naturalist Edward Forbes suggested that no life could survive within the cold, dark ocean depths beyond 500m deep. There was little basis for this statement, and he was proven wrong when telegraph cables were retrieved from depths exceeding 1.7 km deep, with unknown life-forms growing on them. In 1877 the American Alexander Agassiz collected and catalogued marine animals as deep as 4,240 m. He studied their coloration patterns and hypothesized about the absorption of various wavelengths at depth. He also noted similarities between trouble organisms on the east and West Coast of Central America and suggested that the Pacific and Caribbean were once connected.
High Impact List of Articles
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
Macrolides for bronchiectasis and chronic obstructive pulmonary disease: should we worry about antimicrobial resistance?
David J Serisier
Editorial: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
The European Cystic Fibrosis Society - Clinical Trials Network: an international network to optimize clinical research for a rare disease
Isabelle Fajac, Veerle Bulteel, Carlo Castellani, Tim Lee, Nico Derichs,Pavel Drevinek, Luisa Pereira, Christine Dubois, Andreas LG
Reimann, Kris De Boeck
Research Update: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ruxolitinib for myelofibrosis
Clodagh Keohane & Claire Harrison
Review: Clinical Trail Outcomes: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Fixed combination therapies based on direct renin inhibition: a commentary to the ACCELERATE trial
Giuliano Tocci, Diana Chin, Massimo Volpe
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
Relevant Topics in Clinical